Clinical Trials · NCT04387201
GLP-1 Therapy: The Role of IL-6 Signaling and Adipose Tissue Remodeling in Metabolic Response
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- The University of Texas Health Science Center, Houston
- Enrollment
- 23
- Start date
- May 2020
- Locations
- 1 site, United States
- Primary endpoint
- Cytokine Interleukin-6 (IL-6) Messenger Ribonucleic Acid (mRNA) Level (From Adipose Tissue)